Mouse Models of Tumor Immunotherapy.

Area of Science:

• Oncology
• Immunology
• Translational Medicine

Background:

• Immunotherapy is a rapidly advancing cancer treatment modality.
• There is a growing need for novel immunotherapy targets and understanding drug mechanisms.
• Preclinical models are essential for validating new cancer therapies.

Purpose of the Study:

• To review major classes of experimental mouse models for cancer immunotherapy assessment.
• To provide guidance on selecting appropriate models for drug validation.
• To highlight advances in mouse models for personalized cancer therapy.

Main Methods:

• Discussion of commonly used experimental cancer mouse models.
• Presentation of data on carcinogen-induced tumor models for immunotherapy comparison.
• Exploration of combining immunotherapy with chemotherapy in preclinical models.

Main Results:

• Experimental mouse models are vital for assessing immunotherapy efficacy and safety.
• Carcinogen-induced models show utility in comparing immunotherapies and combination treatments.
• Recent advances facilitate the development of personalized cancer therapies in mice.

Conclusions:

• Appropriate selection of mouse models is critical for successful immunotherapy development.
• Mouse models are instrumental in advancing personalized cancer treatment strategies.
• Continued innovation in experimental modeling will accelerate clinical translation of immunotherapies.